Dr. Gal Noyman-Veksler is an investment principal at LionBird, a venture capital firm investing in early-stage digital health companies with operations in the U.S. and Israel.
Gal previously co-founded and served as CEO of NeuroLabs AI, an opioids dependence prevention platform, tackling the opioid epidemic through ongoing assessment of pain and mood symptoms at home. Gal also previously served as VP Business Development and Director of Healthcare at a multinational AI expert firm, and as an investment analyst at aMoon.
Gal holds a PhD in Clinical and Neuro-Psychology in the domains of chronic pain, depression and stress (for which she was awarded the national Wolf Scholarship) and has frequently published in top tier medical journals such as Vaccine and Psychiatry.
Gal is attending / has attended:
VSVC West 2021